The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Open accessAbstract
VEGF treatment versus control, Outcome 16 Reduction in size of lesion at 2 years (mean number of disc areas).................
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Martin, D. F., Maguire, M. G., Fine, S. L., Ying, G.-S., Jaffe, G. J., Grunwald, J. E., Toth, C., Redford, M., & Ferris, F. L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.053 · Cited by 1,715
Brown, D. M., Michels, M., Kaiser, P. K., Heier, J. S., Sy, J. P., & Ianchulev, T. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.10.018 · Cited by 1,318
Leibowitz, H. M., Krueger, D. E., Maunder, L. R., Milton, R. C., KINI, M. M., Kahn, H. A., Nickerson, R. J., Pool, J., Colton, T., Ganley, J. P., et al. (1980) · PubMed · Cited by 1,250
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Rofagha, S., Bhisitkul, R. B., Boyer, D. S., Sadda, S. R., & Zhang, K. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.03.046 · Cited by 1,023
Lalwani, G. A., Rosenfeld, P. J., Fung, A. E., Dubovy, S. R., Michels, S., Feuer, W., Davis, J. L., Flynn, H. W., & Esquiabro, M. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.01.024 · Cited by 880
Regillo, C. D., Brown, D. M., Abraham, P., Yue, H., Ianchulev, T., Schneider, S., & Shams, N. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.10.004 · Cited by 858
How to identify randomized controlled trials in MEDLINE: ten years on.
Glanville, J., Lefebvre, C., Miles, J. N. V., & Camosso‐Stefinovic, J. (2006) · Europe PMC (PubMed Central) · Cited by 833
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
Schmidt-Erfurth, U., Kaiser, P. K., Korobelnik, J.-F., Brown, D. M., Chong, V., Nguyen, Q. D., Ho, A. C., Ogura, Y., Simader, C., Jaffe, G. J., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.08.011 · Cited by 822
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
Chakravarthy, U., Harding, S. P., Rogers, C. A., Downes, S. M., Lotery, A. J., Wordsworth, S., & Reeves, B. C. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.04.015 · Cited by 781
Chakravarthy, U., Harding, S. P., Rogers, C. A., Downes, S. M., Lotery, A. J., Culliford, L. A., & Reeves, B. C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61501-9 · Cited by 748
Maguire, M. G., Martin, D. F., Ying, G.-S., Jaffe, G. J., Daniel, E., Grunwald, J. E., Toth, C. A., Ferris, F. L., & Fine, S. L. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.03.045 · Cited by 708
Kvanta, A., Algvere, P., Berglin, L., & Seregard, S. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70522-7 · Cited by 620
Lopez, P. F., Sippy, B. D., Lambert, H. M., Thach, A. B., & Hinton, D. R. (1998) · Retina · doi:10.1097/00006982-199805000-00035 · Cited by 592
Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials
Grunwald, J. E., Daniel, E., Huang, J., Ying, G.-S., Maguire, M. G., Toth, C. A., Jaffe, G. J., Fine, S. L., Blodi, B., Klein, M. L., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.08.015 · Cited by 590
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Solomon, S. D., Lindsley, K., Vedula, S. S., Krzystolik, M. G., & Hawkins, B. S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005139.pub3 · Cited by 520
Self-citationAbraham, P., Yue, H., & Wilson, L. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.04.011 · Cited by 441
(1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080080069030 · Cited by 413
Berg, K., Pedersen, T. R., Sandvik, L., & Bragadóttir, R. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.07.041 · Cited by 392
Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration
Boyer, D. S., Antoszyk, A. N., Awh, C. C., Bhisitkul, R. B., Shapiro, H., & Acharya, N. R. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.10.045 · Cited by 390
Kaiser, P. K., Brown, D. M., Zhang, K., Hudson, H. L., Holz, F. G., Shapiro, H., Schneider, S., & Acharya, N. R. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.08.012 · Cited by 361
Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Heier, J. S., Antoszyk, A. N., Pavan, P. R., Leff, S. R., Rosenfeld, P. J., Ciulla, T. A., Dreyer, R. F., Gentile, R. C., Sy, J. P., Hantsbarger, G., et al. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.052 · Cited by 360
Boyer, D. S., Heier, J. S., Brown, D. M., Francom, S. F., Ianchulev, T., & Rubio, R. G. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.05.024 · Cited by 347
Bourne, R. R. A., Jonas, J. B., Flaxman, S. R., Keeffe, J., Leasher, J., Naidoo, K., Parodi, M. B., Pesudovs, K., Price, H., White, R. A., et al. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304033 · Cited by 341
Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials
Daniel, E., Toth, C. A., Grunwald, J. E., Jaffe, G. J., Martin, D. F., Fine, S. L., Huang, J., Ying, G.-S., Hagstrom, S. A., Winter, K., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.10.019 · Cited by 335
Lopez, P. F., Sippy, B. D., Lambert, H. M., Thach, A. B., & Hinton, D. R. (1996) · PubMed · Cited by 332
Common causes of blindness and visual handicap in the west of Scotland.
Ghafour, I. M., Allan, D., & Foulds, W. S. (1983) · British Journal of Ophthalmology · doi:10.1136/bjo.67.4.209 · Cited by 306
Ying, G.-S., Huang, J., Maguire, M. G., Jaffe, G. J., Grunwald, J. E., Toth, C., Daniel, E., Klein, M., Pieramici, D., Wells, J., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.07.042 · Cited by 305
Heier, J. S. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.11.1532 · Cited by 304
Kvanta, A., Algvere, P. V., Berglin, L., & Seregard, S. (1996) · PubMed · Cited by 300
The Genetics of Age-Related Macular Degeneration: A Review of Progress to Date
Haddad, S., Chen, C. A., Santangelo, S. L., & Seddon, J. M. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.05.001 · Cited by 299
Jaffe, G. J., Martin, D. F., Toth, C. A., Daniel, E., Maguire, M. G., Ying, G.-S., Grunwald, J. E., & Huang, J. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.01.073 · Cited by 294
Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration
D’Amico, D. J. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.027 · Cited by 260
FRIEDMAN, B. (1941) · Archives of Ophthalmology · doi:10.1001/archopht.1941.00870100042005 · Cited by 260
Kodjikian, L., Souied, E. H., Mimoun, G., Mauget-Faÿsse, M., Behar-Cohen, F., Decullier, E., Huot, L., & Aulagner, G. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.06.020 · Cited by 257
Smoking and Age-Related Maculopathy: The Blue Mountains Eye Study
Smith, W. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140716016 · Cited by 255
Rosenfeld, P. J., Shapiro, H., Tuomi, L., Webster, M., Elledge, J., & Blodi, B. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.07.011 · Cited by 252
Leading causes of certification for blindness and partial sight in England & Wales
Bunce, C., & Wormald, R. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-58 · Cited by 245
Chang, T. S. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.11.1460 · Cited by 239
Dugel, P. U., Jaffe, G. J., Sallstig, P., Warburton, J., Weichselberger, A., Wieland, M., & Singerman, L. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.03.057 · Cited by 236
Sharma, S., Toth, C. A., Daniel, E., Grunwald, J. E., Maguire, M. G., Ying, G.-S., Huang, J., Martin, D. F., & Jaffe, G. J. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.12.002 · Cited by 231
Willoughby, A. S., Ying, G.-S., Toth, C. A., Maguire, M. G., Burns, R. E., Grunwald, J. E., Daniel, E., Jaffe, G. J., Williams, D. F., Beardsley, S., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.05.042 · Cited by 220
Kaiser, P. K., Blodi, B. A., Shapiro, H., & Acharya, N. R. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.04.030 · Cited by 217
Grunwald, J. E., Pistilli, M., Daniel, E., Ying, G.-S., Pan, W., Jaffe, G. J., Toth, C. A., Hagstrom, S. A., Maguire, M. G., & Martin, D. F. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2016.09.012 · Cited by 214
Tufail, A., Patel, P. J., Egan, C., Hykin, P., da Cruz, L., Gregor, Z., Dowler, J., Majid, M. A., Bailey, C., Mohamed, Q., et al. (2010) · BMJ · doi:10.1136/bmj.c2459 · Cited by 213
Owen, C. G. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.3.312 · Cited by 210
Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
Grunwald, J. E., Pistilli, M., Ying, G.-S., Maguire, M. G., Daniel, E., & Martin, D. F. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.11.007 · Cited by 204
Schaumberg, D. A. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.1.55 · Cited by 192
Antoszyk, A. N., Tuomi, L., Chung, C. Y., & Singh, A. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.12.029 · Cited by 190
Krebs, I., Schmetterer, L., Boltz, A., Told, R., Vécsei-Marlovits, V., Egger, S., Schönherr, U., Haas, A., Ansari-Shahrezaei, S., Binder, S., et al. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-302391 · Cited by 189
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
Moja, L., Lucenteforte, E., Kwag, K. H., Bertele, V., Campomori, A., Chakravarthy, U., D'Amico, R., Dickersin, K., Kodjikian, L., Lindsley, K., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011230.pub2 · Cited by 187
Self-citationHolz, F. G., Dugel, P. U., Weissgerber, G., Hamilton, R., Silva, R., Bandello, F., Larsen, M., Weichselberger, A., Wenzel, A., Schmidt, A., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.12.030 · Cited by 184
Smoking and the 5-Year Incidence of Age-Related Maculopathy: The Blue Mountains Eye Study
Mitchell, P. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.10.1357 · Cited by 183
Seddon, J. M., George, S., Rosner, B., & Klein, M. L. (2006) · Human Heredity · doi:10.1159/000094141 · Cited by 176
Sun~er, I. J., Kokame, G. T., Yu, E., Ward, J., Dolan, C., & Bressler, N. M. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3225 · Cited by 170
Berg, K., Hadzalic, E., Gjertsen, I., Forsaa, V., Berger, L. H., Kinge, B., Henschien, H., Fossen, K., Markovic, S., Pedersen, T. R., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.09.018 · Cited by 162
Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness
Raftery, J. P., Clegg, A. P., Jones, J., Tan, S. C., & Lotery, A. J. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.116616 · Cited by 162
Li, E., Donati, S., Lindsley, K. B., Krzystolik, M. G., & Virgili, G. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012208.pub2 · Cited by 162
Self-citationZehetner, C., Kirchmair, R., Huber, S., Kralinger, M. T., & Kieselbach, G. F. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-302451 · Cited by 159
NGUYEN, Q., SHAH, S., Hafiz, G., Quinlan, E., SUNG, J., CHU, K., Cedarbaum, J. M., & Campochiaro, P. A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.055 · Cited by 157
Constable, I. J., Pierce, C. M., Lai, C.-M., Magno, A. L., Degli-Esposti, M. A., French, M. A., McAllister, I. L., Butler, S., Barone, S. B., Schwartz, S. D., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.016 · Cited by 152
Vision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye
Bressler, N. M., Chang, T. S., Suñer, I. J., Fine, J. T., Dolan, C., Ward, J., & Ianchulev, T. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.09.002 · Cited by 150
A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard
Schmucker, C. M., Ehlken, C., Agostini, H., Antes, G., Rücker, G., Lelgemann, M., & Loke, Y. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042701 · Cited by 148
Photodynamic therapy for neovascular age-related macular degeneration
Wormald, R., Evans, J. R., Smeeth, L. L., & Henshaw, K. S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002030.pub3 · Cited by 145
Hagstrom, S. A., Ying, G.-S., Pauer, G. J. T., Sturgill-Short, G. M., Huang, J., Callanan, D. G., Kim, I. K., Klein, M. L., Maguire, M. G., & Martin, D. F. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.11.037 · Cited by 142
Aflibercept for neovascular age-related macular degeneration
Sarwar, S., Clearfield, E., Soliman, M. K., Sadiq, M. A., Baldwin, A. J., Hanout, M., Agarwal, A., Sepah, Y. J., Do, D. V., & Nguyen, Q. D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011346.pub2 · Cited by 142
Anti–Vascular Endothelial Growth Factor Pharmacotherapy for Age-Related Macular Degeneration
Ip, M. S., Scott, I. U., Brown, G. C., Brown, M. M., Ho, A. C., Huang, S. S., & Recchia, F. M. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.08.012 · Cited by 142
Epidemiology of eye disease in the elderly
Hyman, L. (1987) · Eye · doi:10.1038/eye.1987.53 · Cited by 139
Cigarette Smoking, CFH, APOE, ELOVL4, and Risk of Neovascular Age-Related Macular Degeneration
DeAngelis, M. M., Ji, F., Kim, I. K., Adams, S. M., Capone, A., Ott, J., Miller, J. W., & Dryja, T. P. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.1.49 · Cited by 134
Singerman, L. J., Masonson, H., Patel, M., Adamis, A. P., Buggage, R. R., Cunningham, E. T., Goldbaum, M., Katz, B., & Guyer, D. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.132597 · Cited by 132
Lazić, R., & Gabrić, N. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.006 · Cited by 128
Klein, R., Knudtson, M. D., Cruickshanks, K. J., & Klein, B. E. K. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.1.115 · Cited by 121
Ying, G., Maguire, M. G., Daniel, E., Ferris, F. L., Jaffe, G. J., Grunwald, J. E., Toth, C. A., Huang, J., & Martín, D. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.08.015 · Cited by 112
Daniel, E., Shaffer, J., Ying, G., Grunwald, J. E., Martín, D., Jaffe, G. J., & Maguire, M. G. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.10.034 · Cited by 110
Ting, T. D. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.731 · Cited by 109
Chakravarthy, U., Harding, S. P., Rogers, C. A., Downes, S. M., Lotery, A. J., Dakin, H., Culliford, L. A., Scott, L. J., Nash, R. L., Taylor, J., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19780 · Cited by 107
Subramanian, M. L., Abedi, G., Ness, S. D., Ahmed, E., Fenberg, M. J., Daly, M. K., Houranieh, A. M., & Feinberg, E. B. (2010) · Eye · doi:10.1038/eye.2010.147 · Cited by 105
Holz, F. G., Bandello, F. M., Gillies, M. C., Mitchell, P. L. R., Osborne, A. R., Sheidow, T., Souied, E. H., & Figueroa, M. S. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-303232 · Cited by 103
Mitchell, P. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.585394 · Cited by 102
Laser photocoagulation for neovascular age-related macular degeneration
Virgili, G., & Bini, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004763.pub2 · Cited by 99
Bressler, N. M. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2008.562 · Cited by 98
Vedula, S. S., & Krzystolik, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005139.pub2 · Cited by 96
Self-citationSchauwvlieghe, A.-S. M. E., Dijkman, G., Hooymans, J. M. M., Verbraak, F. D., Hoyng, C. B., Dijkgraaf, M. G. W., Pető, T., Vingerling, J. R., & Schlingemann, R. O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153052 · Cited by 95
Cunningham, E. T., Feiner, L., Chung, C. Y., Tuomi, L., & Ehrlich, J. S. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.05.026 · Cited by 94
Maguire, M. G., Daniel, E., Shah, A. R., Grunwald, J. E., Hagstrom, S. A., Avery, R. L., Huang, J., Martin, R. W., Roth, D. B., Castellarin, A. A., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.03.017 · Cited by 93
Bressler, N. M., Boyer, D. S., Williams, D. F., Butler, S. M., Francom, S. F., Brown, B., Nucci, F. D., Cramm, T., Tuomi, L. L., Ianchulev, T., et al. (2012) · Retina · doi:10.1097/iae.0b013e31825db6ba · Cited by 89
C-reactive Protein Level and Risk of Aging Macula Disorder: The Rotterdam Study
Boekhoorn, S. S., Vingerling, J. R., Witteman, J. C. M., Hofman, A., & de Jong, P. T. V. M. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.10.1396 · Cited by 89
BARBAZETTO, I. A., Saroj, N., Shapiro, H., Wong, P., Ho, A. C., & Freund, K. B. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.01.007 · Cited by 89
Stein, J. D., Newman-Casey, P. A., Tavag, M., Lee, P. P., & Hutton, D. W. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.10.037 · Cited by 87
Brown, M. M., Brown, G. C., Brown, H. C., & Peet, J. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.08.033 · Cited by 87
Meredith, T. A., McCannel, C. A., Barr, C. C., Doft, B. H., Peskin, E., Maguire, M. G., Martín, D., & Prenner, J. L. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.10.027 · Cited by 86
Subramanian, M. L., Ness, S. D., Abedi, G., Ahmed, E., Daly, M. K., Feinberg, E. B., Bhatia, S. P., Patel, P. M., Nguyen, M., & Houranieh, A. M. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.07.009 · Cited by 78
Csaky, K. G., Dugel, P. U., Pierce, A. J., Fries, M. A., Kelly, D. S., Danis, R. P., Wurzelmann, J. I., Xu, C., Hossain, M. S., & Trivedi, T. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.09.036 · Cited by 77
Bashshur, Z. F., Schakal, A., Hamam, R. N., Haibi, C. P. E., Jaafar, R. F., & Noureddin, B. N. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.10.1357 · Cited by 77
Biswas, P., Sengupta, S., Choudhary, R., Home, S., Paul, A., & Sinha, S. (2011) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.81023 · Cited by 76
Brown, D. M., Tuomi, L., & Shapiro, H. (2012) · Retina · doi:10.1097/iae.0b013e318263cedf · Cited by 74
Weigert, G., Michels, S., Sacu, S., Varga, A., Prager, F., Geitzenauer, W., & Schmidt-Erfurth, U. M. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.125823 · Cited by 69
Solomon, S. D., Lindsley, K. B., Krzystolik, M. G., Vedula, S. S., & Hawkins, B. S. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.09.002 · Cited by 68
Self-citationLotery, A. J., Gibson, J., Cree, A. J., Downes, S. M., Harding, S. P., Rogers, C. A., Reeves, B. C., Ennis, S., & Chakravarthy, U. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.07.046 · Cited by 64
Pulido, J. S. (2002) · PubMed · Cited by 58
Ciulla, T. A., Ying, G., Maguire, M. G., Martín, D., Jaffe, G. J., Grunwald, J. E., Daniel, E., & Toth, C. A. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.02.031 · Cited by 57
Modarres, M., Naseripour, M., Falavarjani, K. G., Nikeghbali, A., Hashemi, M., & Parvaresh, M. M. (2009) · Retina · doi:10.1097/iae.0b013e318198148e · Cited by 55
Grunwald, J. E., Daniel, E., Ying, G., Pistilli, M., Maguire, M. G., Alexander, J., Martin, R., Parker, C., Sepielli, K., Blodi, B. A., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.02.013 · Cited by 53
Altaweel, M. M., Daniel, E., Martin, D. F., Mittra, R. A., Grunwald, J. E., Lai, M. M., Melamud, A., Morse, L. S., Huang, J., Ferris, F. L., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.08.020 · Cited by 51
Tano, Y., & Ohji, M. (2010) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2009.01843.x · Cited by 50
Gillies, M. C., Walton, R., Arnold, J., McAllister, I. L., Simpson, J. M., Hunyor, A. P., Guymer, R. H., Essex, R. W., Morlet, N., & Barthelmes, D. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.09.050 · Cited by 50
Schmucker, C. M., Ehlken, C., Hansen, L. L., Antes, G., Agostini, H., & Lelgemann, M. (2010) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3283386783 · Cited by 49
Submacular Surgery Trials Research Group* (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.10.1323 · Cited by 48
Photodynamic therapy for neovascular age-related macular degeneration
Wormald, R., Evans, J. R., Smeeth, L. L., & Henshaw, K. S. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002030.pub2 · Cited by 47
Sacu, S., Michels, S., Prager, F., Weigert, G., Dunavoelgyi, R., Geitzenauer, W., Prünte, C. F., & Schmidt-Erfurth, U. M. (2009) · Eye · doi:10.1038/eye.2008.423 · Cited by 45
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
Hurley, S. F., Matthews, J. P., & Guymer, R. H. (2008) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-6-12 · Cited by 43
Hernández-Pastor, L. J., Ortega, A., García‐Layana, A., & Giráldez, J. (2009) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1156-9 · Cited by 39
Quality of life in patients with age-related macular degeneration: results from the VISION study
LEYS, A. M., Zlateva, G., Shah, S. N., & Patel, M. (2007) · Eye · doi:10.1038/sj.eye.6702900 · Cited by 38
Rasmussen, A., & Sander, B. (2014) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000050 · Cited by 37
FALKENSTEIN, I. A., Cheng, L., MORRISON, V. L., Kozak, I., Tammewar, A. M., & Freeman, W. R. (2007) · Retina · doi:10.1097/iae.0b013e3180654240 · Cited by 37
Costagliola, C., Romano, M., Rinaldi, M., dell’Omo, R., Chiosi, F., Menzione, M., & Semeraro, F. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.159343 · Cited by 36
Patel, P. J., Bunce, C., Tufail, A., & the ABC Trial Investigators (2008) · Trials · doi:10.1186/1745-6215-9-56 · Cited by 35
Sadda, S. R., STOLLER, G. L., Boyer, D. S., Blodi, B. A., Shapiro, H., & Ianchulev, T. (2010) · Retina · doi:10.1097/iae.0b013e3181e44599 · Cited by 35
Computerized Model of Cost-Utility Analysis for Treatment of Age-Related Macular Degeneration
Fletcher, E. C., Lade, R. J., Adewoyin, T., & Chong, V. N. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.07.018 · Cited by 33
Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action
Pulido, J. S., Sanders, D. R., & Klingel, R. (2005) · Canadian Journal of Ophthalmology · doi:10.1016/s0008-4182(05)80076-6 · Cited by 32
Hernández-Pastor, L. J., Ortega, A., García‐Layana, A., & Giráldez, J. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.12.025 · Cited by 31
Changes in intraocular pressure in study and fellow eyes in the IVAN trial
Foss, A. J. E., Scott, L. J., Rogers, C. A., Reeves, B. C., Ghanchi, F. D., Gibson, J. M., & Chakravarthy, U. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-307595 · Cited by 29
Hahn, R., Sacu, S., Michels, S., Varga, A., Weigert, G., Geitzenauer, W., Vécsei‐Marlovits, P. V., & Schmidt-Erfurth, U. M. (2007) · Der Ophthalmologe · doi:10.1007/s00347-007-1547-4 · Cited by 26
Earnshaw, S., Moride, Y., & Rochon, S. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.001 · Cited by 26
Lai, T. Y. Y., Liu, D. T. L., Chan, K. M., Luk, F. O. J., Pang, C., & Lam, D. S. C. (2009) · Retina · doi:10.1097/iae.0b013e3181b32c45 · Cited by 26
Keane, P. A., Heussen, F. M., Ouyang, Y., Mokwa, N., Walsh, A. C., Tufail, A., Sadda, S. R., & Patel, P. J. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8130 · Cited by 25
Javitt, J. C., Zlateva, G., Earnshaw, S., Pleil, A. M., Graham, C. N., Brogan, A. J., Shah, S. N., & Adamis, A. P. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00283.x · Cited by 25
Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting
Falcão, Carneiro, Mendonça, Fonseca, S. L., Brandão, & Falcão‐Reis, F. (2012) · Clinical ophthalmology · doi:10.2147/opth.s33017 · Cited by 24
Bevacizumab for Neovascular Age-related Macular Degeneration in China
Li, X., Hu, Y., Sun, X., Zhang, J., & Zhang, M.-N. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.05.016 · Cited by 22
Bressler, N. M., Chang, T. S., Varma, R., Suñer, I. J., Lee, P. P., Dolan, C., Ward, J., Ianchulev, T., & Fine, J. T. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.07.027 · Cited by 22
Fang, K., Tian, J., Qing, X., Li, S., Hou, J., Li, J., Yu, W., Chen, D., Hu, Y., & Li, X. (2013) · Journal of Ophthalmology · doi:10.1155/2013/676049 · Cited by 21
Cost Effectiveness of Pegaptanib for the Treatment of Age-Related Macular Degeneration in the UK
Wolowacz, S. E., Roskell, N., Kelly, S., Maciver, F. M., & Brand, C. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725100-00005 · Cited by 21
Vallance, J. H., Johnson, B., Majid, M. A., Banerjee, S., Mandal, K., & Bailey, C. (2010) · Eye · doi:10.1038/eye.2010.84 · Cited by 19
RETINAL VASCULAR ABNORMALITIES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Jackson, T. L., Danis, R. P., Goldbaum, M., Slakter, J. S., Shusterman, E. M., O’Shaughnessy, D., & Moshfeghi, D. M. (2013) · Retina · doi:10.1097/iae.0b013e3182a487be · Cited by 19
Patel, P. J., Chen, F. K., da Cruz, L., Rubin, G. S., & Tufail, A. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6208 · Cited by 18
Schmid‐Kubista, K. E., Krebs, I., Gruenberger, B., Zeiler, F., Schueller, J., & Binder, S. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.144410 · Cited by 18
Neubauer, A. S., Holz, F. G., Schrader, W. F., Back, E., Kuhn, T. E., Hirneiß, C., & Kampik, A. (2007) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/s-2007-963470 · Cited by 18
Features of age-related macular degeneration on optical coherence tomography.
Kerckhoven, W. V., Lafaut, B. A., Follens, I., & Laey, J. J. D. (2001) · PubMed · Cited by 17
HATTA, Y., Ishikawa, K., NISHIHARA, H., Ozawa, S., Ito, Y., & Terasaki, H. (2010) · Retina · doi:10.1097/iae.0b013e3181bcedbe · Cited by 17
Cohen, S. Y., Brémond‐Gignac, D., Quentel, G., Mimoun, G., Citterio, T., Bisot-Locard, S., & Béresniak, A. (2008) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-008-0890-8 · Cited by 17
Wolf, S., Holz, F. G., Jf, K., Lanzetta, P., Mitchell, P., Prünte, C. F., Schmidt-Erfurth, U. M., Weichselberger, A., & Hashad, Y. (2011) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300471 · Cited by 15
Scholler, A., Richter‐Mueksch, S., Weingessel, B., & Vécsei‐Marlovits, P. V. (2014) · Wiener klinische Wochenschrift · doi:10.1007/s00508-014-0539-z · Cited by 14
BARBAZETTO, I. A., Saroj, N., Shapiro, H., Wong, P., & Freund, K. B. (2010) · Retina · doi:10.1097/iae.0b013e3181dcfb0b · Cited by 14
Ranibizumab Treatment Outcomes in Phakic versus Pseudophakic Eyes
Weinberg, D. V., Shapiro, H., & Ehrlich, J. S. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.11.042 · Cited by 14
Shah, N., Maguire, M. G., Martín, D., Shaffer, J., Ying, G., Grunwald, J. E., Toth, C. A., Jaffe, G. J., & Daniel, E. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.11.030 · Cited by 14
Pegaptanib and Age-Related Macular Degeneration
Rakic, J., Blaise, P., & Foidart, J.-M. (2005) · New England Journal of Medicine · doi:10.1056/nejm200504213521619 · Cited by 14
Mills, E. J., Heels‐Ansdell, D., Kelly, S., & Guyatt, G. H. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.09.001 · Cited by 13
Blaha, G. R., Brooks, N. O., Mackel, C. E., Pani, A., Stewart, A. P., Price, L. L., Barouch, F. C., Chang, J., & Marx, J. L. (2014) · Retina · doi:10.1097/iae.0000000000000334 · Cited by 13
Şengül, E. A., Rasier, R., Ciftci, C., Artunay, Ö., Koçkar, A., Bahçecıoğlu, H., & Yuzbasioglu, E. (2017) · Eye · doi:10.1038/eye.2016.305 · Cited by 13
Wells, J. A., Gonzales, C. R., Berger, B. B., González, V. H., Sippy, B. D., & Burian, G. (2018) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20180501-07 · Cited by 13
Roche and Novartis colluded over wet AMD drugs, says Italian regulator
Cohen, D. R. (2014) · BMJ · doi:10.1136/bmj.g2006 · Cited by 12
Schmid‐Kubista, K. E., Krebs, I., Ansari‐Shahrezaei, S., Haas, P., Hagen, S., & Binder, S. (2011) · Current Eye Research · doi:10.3109/02713683.2011.597536 · Cited by 12
SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration
Enseleit, F., Michels, S., Sudano, I., Stahel, M., Zweifel, S. A., Schlager, O., Becker, M. D., Winnik, S. H., Nägele, M. P., Flammer, A. J., et al. (2017) · Ophthalmologica · doi:10.1159/000478665 · Cited by 12
Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients.
Li, J., Zhang, H., Sun, P., Gu, F., & Liu, Z.-L. (2013) · Europe PMC (PubMed Central) · doi:10.3980/j.issn.2222-3959.2013.02.12 · Cited by 11
VEGF Inhibition Study in Ocular Neovascularization (VISION): Second Year Efficacy Data
D’Amico, D. J. (2005) · Investigative Ophthalmology & Visual Science · Cited by 11
Singerman, L. J., Weichselberger, A., & Sallstig, P. (2015) · Investigative Ophthalmology & Visual Science · Cited by 9
Nowak, M. S., Jurowski, P., Grzybowski, A. E., Goś, R., Pastuszka, M., Kapica, A., & Śmigielski, J. (2012) · Medical Science Monitor · doi:10.12659/msm.882907 · Cited by 9
Marcus, D. M. (2008) · Investigative Ophthalmology & Visual Science · Cited by 8
Parodi, M. B., Cascavilla, M. L., Papayannis, A., Kontadakis, D. S., Bandello, F. M., & Iacono, P. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.2617 · Cited by 8
Chakravarthy, U., Staurenghi, G., Kwok, K. K., Tressler, C. S., Buggage, R. R., & For The PERSPECTIVES Study Group (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301444 · Cited by 8
Donahue, S. P., Recchia, F. M., & Sternberg, P. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.04.006 · Cited by 8
Krzystolik, M., Woodcome, H., & Reddy, U. U. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005139 · Cited by 8
Self-citationBrown, D. M., Shapiro, H., & Schneider, S. (2006) · Investigative Ophthalmology & Visual Science · Cited by 7
Comparing treatments for age-related macular degeneration: safety, effectiveness and cost.
Maguire, M. G. (2012) · PubMed · Cited by 7
Li, X., Chen, Y., Zhang, J., Xu, X., Zhang, F., Cheung, C. M. G., Yu, R., Kazmi, H., Sowade, O., Zeitz, O., et al. (2017) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2016.0071 · Cited by 6
[Pegaptanib sodium one-year treatment study for neovascular age-related macular degeneration].
Tano, Y. (2008) · PubMed · Cited by 5
Li, E., Donati, S., Virgili, G., & Krzystolik, M. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012208 · Cited by 5
Self-citationVERITAS – The Rationale and Design of a Combination Therapy Trial For Wet AMD
Mieler, W. F. (2006) · Investigative Ophthalmology & Visual Science · Cited by 4
Yang, Y. C. (2007) · Investigative Ophthalmology & Visual Science · Cited by 4
Larsen, M., Sander, B., Je, V., Ph, H., la Cour, M., & Lund‐Andersen, H. (2005) · PubMed · Cited by 4
Rosenfeld, P. J., Shapiro, H., Shams, N., Schneider, S., Depperschmidt, E. E., Marina, M., & Groups, A. S. (2007) · Investigative Ophthalmology & Visual Science · Cited by 3
Tano, Y. (2008) · Investigative Ophthalmology & Visual Science · Cited by 3
Sutter, F., & Kurz-Levin, M. M. (2008) · Investigative Ophthalmology & Visual Science · Cited by 3
Ho, A. C., Yue, H., & Wilson, L. (2008) · Investigative Ophthalmology & Visual Science · Cited by 3
Chang, T., Bressler, N. M., Fine, J. T., Dolan, C., & Ward, J. (2007) · Investigative Ophthalmology & Visual Science · Cited by 3
Yu, E., Bressler, N. M., Fine, J. T., Ward, J., Dolan, C., Klesert, T. R., & Chang, T. (2007) · Investigative Ophthalmology & Visual Science · Cited by 3
Schwartz, S. G., Bressler, N. M., Fine, J. T., Dolan, C., Yu, E., Ward, J., & Chang, T. (2007) · Investigative Ophthalmology & Visual Science · Cited by 3
Messori, A., Fadda, V., & Trippoli, S. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.12.039 · Cited by 3
Suñer, I. J., Bressler, N. M., Chang, T., Fine, J. T., Dolan, C., & Ward, J. (2007) · Investigative Ophthalmology & Visual Science · Cited by 3
(2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.06.029 · Cited by 3
Win, P. H., Bressler, N. M., Chang, T., Fine, J. T., Dolan, C., & Ward, J. (2008) · Investigative Ophthalmology & Visual Science · Cited by 2
Bolz, M., Pruente, C., Benesch, T., Ritter, M., Deák, G. G., Golbaz, I., & Schmidt-Erfurth, U. M. (2008) · Investigative Ophthalmology & Visual Science · Cited by 2
Lanzetta, P., Anchor, & Groups, P. S. (2008) · Investigative Ophthalmology & Visual Science · Cited by 2
Wolf, S., & Faculty, A. (2008) · Investigative Ophthalmology & Visual Science · Cited by 2
Monotherapie der exsudativen altersbedingten Makuladegeneration bei kardiovaskulären Risikopatienten
Matthé, E., & Sandner, D. (2010) · Der Ophthalmologe · doi:10.1007/s00347-010-2300-y · Cited by 2
[Antiangiogenesis therapy of age-related macular degeneration].
Sjølie, A. K., Mortensen, K. K., & Hansen, M. H. (2005) · PubMed · Cited by 2
Schmid‐Kubista, K. E., Krebs, I., Gruenberger, B., Schueller, J., & Binder, S. (2008) · Investigative Ophthalmology & Visual Science · Cited by 2
Cited by
Age-Related Macular Degeneration: A Review
Fleckenstein, M., Schmitz-Valckenberg, S., & Chakravarthy, U. (2024) · JAMA · doi:10.1001/jama.2023.26074 · Cited by 549
Age-Related Macular Degeneration Preferred Practice Pattern®
Flaxel, C. J., Adelman, R. A., Bailey, S. T., Fawzi, A., Lim, J. I., Vemulakonda, G. A., & Ying, G.-S. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.09.024 · Cited by 349
Evans, R. N., Reeves, B. C., Maguire, M. G., Martin, D. F., Muldrew, A., Peto, T., Rogers, C., & Chakravarthy, U. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.3001 · Cited by 145
Sahni, J., Dugel, P. U., Patel, S. S., Chittum, M. E., Berger, B., del Valle Rubido, M., Sadikhov, S., Szczesny, P., Schwab, D., Nogoceke, E., et al. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.2685 · Cited by 129
Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update
Lin, F.-L., Wang, P.-Y., Chuang, Y.-F., Wang, J.-H., Wong, V. H. Y., Bui, B. V., & Liu, G.-S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.029 · Cited by 74
Metadata
- Authors
- Solomon, S. D., Lindsley, K., Vedula, S. S., Krzystolik, M. G., & Hawkins, B. S.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2019-03-04
- Volume
- 2019
- Issue
- 3
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W3029640339
- Cited by
- 271
- References
- 201
- FWCI
- 32.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.